Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Asset Utilization Ratio (2022 - 2025)

InMed Pharmaceuticals (INM) has 4 years of Asset Utilization Ratio data on record, last reported at 0.37 in Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 27.95% year-over-year to 0.37; the TTM value through Dec 2025 reached 0.37, down 27.95%, while the annual FY2025 figure was 0.36, 1.72% up from the prior year.
  • Asset Utilization Ratio reached 0.37 in Q4 2025 per INM's latest filing, up from 0.33 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.55 in Q1 2025 and bottomed at 0.08 in Q2 2022.
  • Average Asset Utilization Ratio over 4 years is 0.33, with a median of 0.37 recorded in 2025.
  • Peak YoY movement for Asset Utilization Ratio: soared 308.98% in 2023, then dropped 27.95% in 2025.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.1 in 2022, then skyrocketed by 308.98% to 0.42 in 2023, then grew by 21.52% to 0.51 in 2024, then decreased by 27.95% to 0.37 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.37 in Q4 2025, 0.33 in Q3 2025, and 0.4 in Q2 2025.